KALA BIO, Inc. (KALA) Financials

KALA Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 61.1 million 49.9 million
2023-06-30 66.5 million 49.0 million
2023-03-31 72.2 million 48.8 million
2022-12-31 86.8 million 67.8 million

KALA Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -3.2 million 2.4 million
2023-06-30 -7.8 million 1.4 million
2023-03-31 -9.8 million 1.3 million
2022-12-31 -13.8 million 960000

KALA Net Income

No data available :(

KALA Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 56.1 million - 2.2 million
2023-06-30 59.2 million 33.6 million -
2023-03-31 63.6 million 33.3 million 3000
2022-12-31 70.5 million - 13000

KALA Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 2.6 million
2023-06-30 2.4 million
2023-03-31 2.1 million
2022-12-31 1.6 million

KALA Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 281000 5.6 million 5.0 million -
2023-06-30 214000 4.3 million 5.0 million -
2023-03-31 108000 4.0 million 6.0 million -
2022-12-31 22000 3.3 million 5.8 million -

KALA Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 157000
2023-06-30 - 77000
2023-03-31 - 87000
2022-12-31 1.2 million 2.6 million

KALA

Price: $7.01

52 week price:
5.10
19.35

Earnings Per Share: -17.35 USD

P/E Ratio: -0.33

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 3.0 million

Ebitda: -9.9 million

Market Capitalization: 20.3 million

Links: